Conformis Inc. [NASDAQ: CFMS] jumped around 0.02 points on Monday, while shares priced at $0.86 at the close of the session, up 1.96%. The company report on May 10, 2021 that Conformis, Inc. Announces 510(k) Clearance for Identity Imprint™ Knee Replacement System.
Leveraging Conformis’ extensive library of personalized knee design data and patient images, Identity Imprint is designed to match patients’ anatomy with an optimal arthroplasty solution while at the same time offering greater efficiency, cost savings, increased intraoperative flexibility, and faster delivery times.
Conformis, Inc. (NASDAQ:CFMS) announced 510(k) clearance by the U.S. Food and Drug Administration for the Company’s Identity Imprint Knee Replacement System.
Conformis Inc. stock is now 30.00% up from its year-to-date (YTD) trading value. CFMS Stock saw the intraday high of $1.05 and lowest of $0.841 per share. The company’s 52-week high price is 1.49, which means current price is +34.06% above from all time high which was touched on 02/09/21.
Compared to the average trading volume of 5.06M shares, CFMS reached a trading volume of 43167212 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Conformis Inc. [CFMS]?
BTIG Research have made an estimate for Conformis Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 01, 2019. The new note on the price target was released on January 02, 2018, representing the official price target for Conformis Inc. stock. On August 04, 2017, analysts decreased their price target for CFMS shares from 6 to 5.
The Average True Range (ATR) for Conformis Inc. is set at 0.07, with the Price to Sales ratio for CFMS stock in the period of the last 12 months amounting to 2.30. The Price to Book ratio for the last quarter was 1.28, with the Price to Cash per share for the same quarter was set at 0.59.
How has CFMS stock performed recently?
Conformis Inc. [CFMS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.32. With this latest performance, CFMS shares dropped by -4.37% in over the last four-week period, additionally plugging by 30.99% over the last 6 months – not to mention a drop of -9.82% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CFMS stock in for the last two-week period is set at 43.26, with the RSI for the last a single of trading hit 42.62, and the three-weeks RSI is set at 44.21 for Conformis Inc. [CFMS]. The present Moving Average for the last 50 days of trading for this stock 0.9561, while it was recorded at 0.8557 for the last single week of trading, and 0.8502 for the last 200 days.
Conformis Inc. [CFMS]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Conformis Inc. [CFMS] shares currently have an operating margin of -36.52 and a Gross Margin at +49.03. Conformis Inc.’s Net Margin is presently recorded at -35.33.
Return on Total Capital for CFMS is now -59.84, given the latest momentum, and Return on Invested Capital for the company is -60.10. Return on Equity for this stock declined to -175.28, with Return on Assets sitting at -33.76. When it comes to the capital structure of this company, Conformis Inc. [CFMS] has a Total Debt to Total Equity ratio set at 264.28. Additionally, CFMS Total Debt to Total Capital is recorded at 72.55, with Total Debt to Total Assets ending up at 42.03. Long-Term Debt to Equity for the company is recorded at 250.04, with the Long-Term Debt to Total Capital now at 68.64.
Reflecting on the efficiency of the workforce at the company, Conformis Inc. [CFMS] managed to generate an average of -$93,795 per employee. Receivables Turnover for the company is 6.55 with a Total Asset Turnover recorded at a value of 0.96.Conformis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.90 and a Current Ratio set at 4.30.
Earnings analysis for Conformis Inc. [CFMS]
With the latest financial reports released by the company, Conformis Inc. posted -0.03/share EPS, while the average EPS was predicted by analysts to be reported at -0.1/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 70.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CFMS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Conformis Inc. go to -14.58%.
Insider trade positions for Conformis Inc. [CFMS]
There are presently around $35 million, or 32.70% of CFMS stock, in the hands of institutional investors. The top three institutional holders of CFMS stocks are: WASATCH ADVISORS INC with ownership of 17,719,186, which is approximately New of the company’s market cap and around 1.60% of the total institutional ownership; RENAISSANCE TECHNOLOGIES LLC, holding 5,882,971 shares of the stock with an approximate value of $4.95 million in CFMS stocks shares; and ARCHON CAPITAL MANAGEMENT LLC, currently with $3.25 million in CFMS stock with ownership of nearly 0% of the company’s market capitalization.
Positions in Conformis Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 26 institutional holders increased their position in Conformis Inc. [NASDAQ:CFMS] by around 24,088,414 shares. Additionally, 18 investors decreased positions by around 9,096,792 shares, while 25 investors held positions by with 8,341,059 shares. The mentioned changes placed institutional holdings at 41,526,265 shares, according to the latest SEC report filing. CFMS stock had 11 new institutional investments in for a total of 21,039,067 shares, while 9 institutional investors sold positions of 8,221,917 shares during the same period.